Calendar
event
Ex dividend date
15 Sept 2025
event_available
Last Dividend Payment
03 Oct 2025
About CONMED Corporation
Ticker
info
CNMD
Trading on
info
NYSE
ISIN
info
US2074101013
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
Patrick J. Beyer
Headquarters
info
11311 Concept Boulevard, Largo, FL, United States, 33773-4908
Employees
info
3,900
Website
info
conmed.com
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.
Metrics
BasicAdvanced
Market cap
info
$1.37B
P/E ratio
info
21.58
EPS
info
$2.05
Dividend Yield
info
1.80%
Beta
info
0.98
Forward P/E ratio
info
27.03
EBIDTA
info
$226M
Ex dividend date
info
2025-09-15
Price & volume
Market cap
info
$1.37B
Average daily volume
info
0.6M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.80
Dividend yield
info
1.80%
Forward dividend per share
info
$0.80
Forward dividend yield
info
1.80%
Payout ratio
info
19.70%
Valuation
P/E ratio
info
21.58
Forward P/E
info
27.03
PEG ratio
info
5.29
Trailing P/E
info
21.58
Price to sales
info
1.02
Price to book
info
1.36
Earnings
EPS
info
$2.05
EPS estimate (current quarter)
info
$1.05
EPS estimate (next quarter)
info
$1.32
EBITDA
info
$226M
Revenues (TTM)
info
$1.35B
Revenues per share (TTM)
info
$43.46
Technicals
Beta
info
0.98
52-week High
info
$75.30
52-week Low
info
$38.95
50-day moving average
info
$45.00
200-day moving average
info
$52.42
Short ratio
info
5.15
Short %
info
9.92%
Management effectiveness
ROE (TTM)
info
6.60%
ROA (TTM)
info
4.15%
Profit margin
info
4.76%
Gross profit margin
info
$761M
Operating margin
info
10.84%
Growth
Quarterly earnings growth (YoY)
info
-94.30%
Quarterly revenue growth (YoY)
info
6.70%
Share stats
Outstanding Shares
info
31M
Float
info
30.7M
Insiders %
info
0.59%
Institutions %
info
114.19%
Analyst Insights & forecasts
info

34% Buy

66% Hold

0% Sell

Based on information from 6 analysts.

Average price target

info
$54.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$1.34
$1.20
11.67%
Q4 • 24Beat
$0.95
$0.81
17.28%
Q1 • 25Beat
$0.69
$0.95
-27.37%
Q2 • 25Missed
$1.08
$1.05
2.86%
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$342M
$21.4M
6.26%
Q2 • 25
$338M
$2.9M
0.85%
Q3 • 25
-1.29%
-86.65%
-86.48%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$2.33B
$1.33B
56.93%
Q2 • 25
$2.32B
$1.31B
56.59%
Q3 • 25
-0.26%
-0.86%
-0.60%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$29.1M
$-5.7M
$-26.5M
$23.4M
Q2 • 25
$53.7M
$-5.2M
$-43.5M
$48.5M
Q3 • 25
84.27%
-9.46%
64.08%
107.22%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a CONMED Corporation share?
Collapse

CONMED Corporation shares are currently traded for undefined per share.

How many shares does CONMED Corporation have?
Collapse

CONMED Corporation currently has 31M shares.

Does CONMED Corporation pay dividends?
Collapse

Yes, CONMED Corporation does pay dividends.

What is CONMED Corporation 52 week high?
Collapse

CONMED Corporation 52 week high is $75.30.

What is CONMED Corporation 52 week low?
Collapse

CONMED Corporation 52 week low is $38.95.

What is the 200-day moving average of CONMED Corporation?
Collapse

CONMED Corporation 200-day moving average is $52.42.

Who is CONMED Corporation CEO?
Collapse

The CEO of CONMED Corporation is Patrick J. Beyer.

How many employees CONMED Corporation has?
Collapse

CONMED Corporation has 3,900 employees.

What is the market cap of CONMED Corporation?
Collapse

The market cap of CONMED Corporation is $1.37B.

What is the P/E of CONMED Corporation?
Collapse

The current P/E of CONMED Corporation is 21.58.

What is the EPS of CONMED Corporation?
Collapse

The EPS of CONMED Corporation is $2.05.

What is the PEG Ratio of CONMED Corporation?
Collapse

The PEG Ratio of CONMED Corporation is 5.29.

What do analysts say about CONMED Corporation?
Collapse

According to the analysts CONMED Corporation is considered a hold.